chr2-105038208-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000258455.8(MRPS9):āc.116A>Cā(p.Gln39Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000258455.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPS9 | NM_182640.3 | c.116A>C | p.Gln39Pro | missense_variant | 1/11 | ENST00000258455.8 | NP_872578.1 | |
MRPS9 | XM_047445533.1 | c.116A>C | p.Gln39Pro | missense_variant | 1/7 | XP_047301489.1 | ||
MRPS9-AS2 | NR_110603.1 | n.43+246T>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPS9 | ENST00000258455.8 | c.116A>C | p.Gln39Pro | missense_variant | 1/11 | 1 | NM_182640.3 | ENSP00000258455.3 | ||
MRPS9-AS2 | ENST00000456519.2 | n.43+246T>G | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246304Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133236
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460210Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726258
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.116A>C (p.Q39P) alteration is located in exon 1 (coding exon 1) of the MRPS9 gene. This alteration results from a A to C substitution at nucleotide position 116, causing the glutamine (Q) at amino acid position 39 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at